Entecavir (commercial name Baraclude) is an oral antiviral drug discovered at the pharmaceutical company Bristol-Myers Squibb; it is designed to selectively inhibit the Hepatitis B virus, blocking all three steps in the replication process.
This drug has been accepted by the US Food and Drug Administration (FDA) in March 2005; it is more efficient than an older Hepatitis B drug, lamivudine.
More on [ Entecavir ]

Baraclude (entecavir) - Prescription medicine used for chronic infection with hepatitis B virus (HBV) in adults. Provides full prescribing information.
Meta Description: [ BARACLUDE (entecavir) is a prescription medicine used for chronic infection with hepatitis B virus (HBV) in adults where the virus is multiplying and damaging the liver. ]
MedlinePlus: Entecavir - Provides information on usage, precautions, side effects and brand names when available. Data provided by government agencies and health-related organizations.
Meta Description: [ Entecavir ]
| professor from South China normal university | |
| Next Video | |